Novo Holdings to Acquire Benchmark Genetics
November 25, 2024
Novo Holdings agreed to acquire Benchmark Genetics from Benchmark Holdings plc for an enterprise value of up to £260 million. Completion is expected in the first quarter of 2025, subject to shareholder approval and regulatory clearances, with initial consideration of £230 million plus up to £30 million contingent on revenue thresholds.
- Buyers
- Novo Holdings
- Targets
- Benchmark Genetics
- Sellers
- Benchmark Holdings plc
- Industry
- Biotechnology
- Location
- Norway
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.